Skip to content

    Depression Health Center

    Font Size

    Drug May Improve Depression and Sleep

    Study Shows Agomelatine May Help Regulate Mood and Sleep-Wake Cycles
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    May 17, 2011 -- An antidepressant that modifies sleep-wake cycles proved effective for treating major depression while also improving the sleep quality of patients in key studies, according to a newly published study.

    The melatonin-based drug agomelatine was recently approved in Europe and Australia for the treatment of depression, but studies are still under way in the U.S.

    There is a growing recognition of the link between depression and disturbances in the 24-hour sleep-wake cycle known as circadian rhythm, study researcher Naomi L. Rogers, PhD, tells WebMD.

    Most people who are depressed also report sleep problems, which can include not being able to get to sleep, fitful sleep, early-morning awakening, and daytime fatigue.

    "Circadian disruption seems to be co-morbid [occurring together] in most mood and psychiatric disorders, especially depression," she says. "We now understand that if we can improve sleep symptoms, this often improves mood symptoms and quality of life."

    Improving Sleep and Depression

    Like melatonin and the melatonin-based therapies used to treat sleep disorders, agomelatine binds to key receptors in the brain that regulate the circadian system. But the drug is unique in that it also blocks receptors for the chemical serotonin, which helps regulate mood.

    Rogers says the drug's antidepressant effect appears to result from this combination of melatonin binding and serotonin blocking.

    Along with psychiatrist Ian B. Hickie, of the University of Sydney, Rogers reviewed studies comparing agomelatine and other drugs or placebo for the treatment of depression.

    The analysis, published in the May 18 edition of TheLancet, was funded by a grant from the Australian government. The drug's manufacturer, Servier Laboratories, provided data and suggested additional references for the reviewers. Rogers is also the recipient of an unrestricted educational grant from Servier.

    In several of the reviewed studies, the drug was found to be as effective as several widely prescribed selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs), including Effexor, Prozac, and Zoloft, Rogers says.

    When compared with placebo, about half as many patients taking agomelatine relapsed (24% vs. 50%) during the observation period. And patients in many of the studies reported improved sleep quality and reduced waking after going to sleep.

    Today on WebMD

    Differences between feeling depressed and feeling blue.
    jk rowling
    Famous people who've struggled with persistent sadness.
    depressed man sitting on hallway floor
    Learn the truth about this serious illness.
    Sad woman looking out of the window
    Tips to stay the treatment course.
    unhappy teen boy
    Health Check
    jk rowling
    Pills with smiley faces
    Teen girl huddled outside house
    Depressed man sitting in hospital hallway
    antidepressants slideshow
    pill bottle
    Winding path